pasireotide long acting release (LAR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pasireotide long acting release (LAR), covering 2022-01-18 to 2022-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) [Phase 2]